B+
Bull case
20%
Probability
Target price
$44.35
+1.5% vs current
Coverage is sparse and consensus price targets cluster below the current market price, implying limited upside. Short-term tone is cautious and tied to reserve and underwriting clarity.
No evidence quality warning is currently attached to this memo.
Proxy and AGM disclosures (capital-return signals, governance) may alter buyback/dividend expectations; timing assumed within the proxy cycle.
Next quarterly earnings and reserve commentary could move the stock intraday depending on combined ratio and reserve disclosures; assumed date used where none published.
Sustained improvement or deterioration in loss ratios and reserve development could re-rate the multiple over 12 months if trends persist.
No formal recommendation provided.